GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation

Bone Marrow Transplantation, Published online: 09 August 2023; doi:10.1038/s41409-023-02033-0GVHD prophylaxis with post-transplant cyclophosphamide results in lower incidence of GVHD and allows faster immunosuppressive treatment reduction compared to antithymocyte globulin in 10/10 HLA-matched unrelated allogeneic hematopoietic cell transplantation

Source: Bone Marrow Transplantation - August 9, 2023 Category: Hematology Authors: Fran çois Dachy Sabine Furst Boris Calmels Thomas Pagliardini Samia Harbi Benjamin Bouchacourt Anne Calleja Claude Lemarie Aude Collignon Guillaume Morel Faezeh Legrand Elena Bekrieva Angela Granata Pierre Jean Weiller Christian Chabannon Jean Marc Schia Source Type: research